← Back to Patent Explorer
US5082650A Expired / Lapsed US ⏱️ 0.0 years remaining

Amelioration of reductions of coenzyme Q10 in cardiomyopathy patients receiving lovastatin

Assignee: Folkers Karl Foundation for Biomedical and Clinical Research
•
Filing: 1989-09-07
•
Granted: 1992-01-21
•
Expires: 2009-09-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention comprises the serious side effect of mevinolin to depress body levels of coenzyme Q10 and to correspondingly depress cardiac function and the circumvention of this side effect by the clinical administration of a formulation of coenzyme Q10 concommitantly with the administration of the mevinolin.

Inventors

  • 👤 Karl A. Folkers
  • 👤 Per H. Langsjoen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 08:14
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/365

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 57 words
A method of ameliorating the reduction of coenzyme Q10 in a patient receiving mevinolin for the treatment of dilated or ischemic cardiomyopathy, said method comprising the concurrent administration of coenzyme Q10 in amounts effective to maintain clinically effective blood levels of coenzyme Q10 and mevinolin in amounts effective to produce clinically effective reductions in levels of cholesterol.
Claim 2
Independent Claim 57 words
A method of ameliorating the reduction of coenzyme Q10 in a patient receiving mevinolin for the treatment of dilated or ischemic cardiomyopathy, said method comprising the concurrent administration of coenzyme Q10 in amounts effective to maintain clinically effective blood levels of coenzyme Q10 and mevinolin in amounts effective to produce clinically effective reductions in levels of cholesterol.

References Cited (Backward Citations)

US4933165A Cited
US4929437A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-01-20 1995-07-22 1996-01-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-01-20 1999-07-22 2000-01-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-01-20 2003-07-22 2004-01-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag